33 studies found for:    DatSCAN
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms
Condition: Parkinsonian Syndromes
Intervention: Procedure: DaTSCAN SPECT imaging
2 Enrolling by invitation DaTSCAN Imaging in Aging and Neurodegenerative Disease
Conditions: Dementia;   Parkinsonism;   Mild Cognitive Impairment;   REM Sleep Behavior Disorder
Interventions: Drug: I-123 Ioflupane solution injection prior to SPECT scan (DaTscan);   Device: Single photon emission computed tomography (SPECT) scan
3 Enrolling by invitation Validation of DaTscan for Detection of Parkinson Disease Related Disorders
Conditions: Parkinson Disease;   Movement Disorders
Intervention: Drug: l-123 Ioflupane
4 Active, not recruiting Compare Rates of Agreement Between Clinical Diagnosis and Visual Assessment of DaTscan™ Images in Non-Caucasian and Caucasian Subjects With Parkinson's Disease (PD) or Essential Tremor (ET)
Conditions: Essential Tremor;   Parkinson's Disease
Intervention: Other: Subjects dosed in a separate study
5 Completed Imaging of Vesicular Acetylcholine and Dopamine Transporters in Dementia With Lewy Bodies
Condition: Dementia With Lewy Bodies
Interventions: Other: Imaging with IBVM;   Other: Imaging with DATSCAN;   Behavioral: neuropsychological evaluation
6 Unknown  Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients With Different Genetic Characteristics
Condition: Parkinson Disease
Intervention:
7 Not yet recruiting Co-LEsions in Alzheimer Disease and Related Disorders
Conditions: Alzheimer's Disease;   Cerebrovascular Disease;   Lewy Body Disease
Intervention: Radiation: SPECT-DaTscan
8 Completed Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM
9 Completed Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
Conditions: Lewy Body Dementia;   Non-DLB Dementia;   Alzheimer’s;   Vascular Dementia
Intervention: Drug: DatSCAN
10 Recruiting DatScan With Prototype Collimator
Condition: Parkinson Disease
Intervention: Device: Prototype UHRSZ (UltraHigh Resolution Smart Zoom) Collimator
11 Completed Diagnostic of Lewy Body Dementia by Combining Scintigraphy (SPECT) Using a Specific Transporter and Magnetic Resonance Imaging (MRI)
Condition: Lewy Body Dementia
Intervention: Procedure: Single photon emission computed tomography and Magnetic Resonance Imaging
12 Completed Dopaminergic Loss and Pain in Parkinson's Disease
Conditions: Parkinson's Disease;   Pain
Intervention: Drug: ioflupane 123I (DATSCAN®)
13 Completed Imaging Biomarkers of Delayed Sequelae in Trauma Brain Injury
Conditions: Traumatic Brain Injury;   Parkinson's Disease
Intervention:
14 Recruiting Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression
Condition: Parkinson Disease
Intervention: Drug: Datscan and AV-133
15 Recruiting Relationship Between Symptoms, Retinal Morphology, and the Nigrostriatal Dopamine System in Parkinson's Disease
Condition: Parkinson's Disease
Intervention:
16 Recruiting Systemic Synuclein Sampling Study (S4)
Condition: Parkinson's Disease
Interventions: Procedure: Biofluid samplings;   Procedure: Tissue samplings;   Drug: DaTSCAN™
17 Unknown  Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives
Condition: Parkinson Disease
Intervention:
18 Completed Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
Conditions: Parkinson Disease;   Parkinsonian Syndrome
Interventions: Drug: cabergoline;   Drug: carbidopa/levodopa;   Procedure: DATscan and SPECT imaging
19 Not yet recruiting A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes
Condition: Parkinson's Syndrome
Interventions: Drug: NAV5001;   Drug: DaTscan
20 Recruiting Diagnosis of PD and PD Progression Using DWI
Condition: Parkinson's Disease
Intervention: Other: Diffusion Weighted Imaging (DWI)

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Indicates status has not been verified in more than two years